Dare Bioscience
DARE
30 hedge funds and large institutions have $6.1M invested in Dare Bioscience in 2021 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 5 closing their positions.
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
11% more funds holding
Funds holding: 27 → 30 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.29% less ownership
Funds ownership: 1.01% → 0.72% (-0.29%)
9% less capital invested
Capital invested by funds: $6.67M → $6.1M (-$575K)
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$335K |
| 2 |
Squarepoint
New York
|
+$289K |
| 3 |
VF
Virtu Financial
New York
|
+$257K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$98K |
| 5 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
+$50.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.21M |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$193K |
| 3 |
Goldman Sachs
New York
|
-$186K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$87K |
| 5 |
Two Sigma Investments
New York
|
-$39K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
UBS Group
Zurich,
Switzerland
| $1K | – | – | – |
|
27
Barclays
London,
United Kingdom
| $1K | +$707 | +29 | New |
|
|
PFGIA
28
Patriot Financial Group Insurance Agency
Westborough,
Massachusetts
| $1K | +$805 | +33 | New |
|
|
GCP
29
GSA Capital Partners
London,
United Kingdom
| – | -$193K | -12,027 | Closed |
|
|
30
Citadel Advisors
Miami,
Florida
| – | -$87K | -5,381 | Closed |
|
|
31
Two Sigma Investments
New York
| – | -$39K | -2,433 | Closed |
|
|
IA
32
Inspire Advisors
Meridian,
Idaho
| – | -$1K | -39 | Closed |
|
33
Wells Fargo
San Francisco,
California
| – | +$24 | +1 | +5% |
|
34
Rockefeller Capital Management
New York
| – | +$415 | +17 | New |
|
DARE Hedge Fund Activity: Q1 2021 in Review
30 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q1 2021, worth a combined $6.1M — down 8.6% from $6.67M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new DARE positions and 5 closed out — a net gain of 4 holders — while 6 added to existing stakes and 9 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $335K. The largest seller was Vanguard Group, cutting an estimated $3.21M.
- 30 institutional investors held Dare Bioscience (DARE) as of Q1 2021, up from 27 in Q4 2020.
- Funds reported $6.1M of Dare Bioscience stock for Q1 2021, down 8.6% quarter-over-quarter.
- 9 funds opened new Dare Bioscience positions in Q1 2021 and 5 closed out, a net change of +4 holders.
- The largest Dare Bioscience buyer in Q1 2021 was Renaissance Technologies, an estimated $335K added.
- The largest Dare Bioscience seller in Q1 2021 was Vanguard Group, an estimated $3.21M sold.
Based on aggregated 13F filings for Q1 2021.